Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.96M | 2.06M | 1.48M | 1.79M | 2.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.96M | 2.06M | 1.48M | 1.79M | 2.00M |
| Operating Income | -1.96M | -2.06M | -1.48M | -1.79M | -2.00M |
| Income Before Tax | -1.88M | -2.02M | -1.49M | -1.76M | -6.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.88M | -2.02M | -1.49M | -1.76M | -6.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.88M | -2.02M | -1.49M | -1.76M | -6.25M |
| EBIT | -1.96M | -2.06M | -1.48M | -1.79M | -2.00M |
| EBITDA | -1.88M | -1.98M | -1.40M | -1.71M | -1.92M |
| EPS Basic | -1.49 | -2.45 | -3.74 | -8.49 | -34.41 |
| Normalized Basic EPS | -0.95 | -1.53 | -2.29 | -5.30 | -21.51 |
| EPS Diluted | -1.49 | -2.45 | -3.74 | -8.49 | -34.41 |
| Normalized Diluted EPS | -0.95 | -1.53 | -2.29 | -5.30 | -21.51 |
| Average Basic Shares Outstanding | 1.26M | 823.10K | 397.50K | 207.60K | 181.80K |
| Average Diluted Shares Outstanding | 1.26M | 823.10K | 397.50K | 207.60K | 181.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |